Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Merck

US drug firm Merck says existing Trump tariffs will cost it $200m this year

Company’s forecast does not account for threatened ‘major’ tariff that could also be levied on pharmaceutical imports

The Guardian - UK

Dow Jones Falls On Trump Tariff News; Nvidia, Tesla Rally

The Dow Jones dropped Thursday on Trump tariff news. Nvidia and Tesla were early winners on the stock market today.

Investors Business Daily

Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan

Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its HPV vaccine, Gardasil.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

Investors Business Daily

Option Volatility And Earnings Report For April 22-24

Earnings season heats up this week with all eyes on Tesla and Alphabet. Other big names reporting this week include Intel, Verizon, Nemont Mining, Boeing, Chipotle Mexican Grill, Proctor & Gamble and Merck.

Barchart

Streak Analysis Alert: Why Merck (MRK) Should Be on Your Radar This Week

Blue chips like MRK stock generally represent a 50/50 wager for any given week. However, certain conditions strongly tilt the odds toward one side of the spectrum.

Barchart

The sudden dismissal of public records staff at health agencies threatens government accountability

Mass layoffs at the Department of Health and Human Services are continuing as the agency makes good on its intention, announced on March 27, 2025, to shrink its workforce by 20,000 people. Among workers dismissed in early April were several teams responsible for fulfilling requests for access to previously unreleased…

The Conversation

Read news from The Economist, FT, and more,
with one subscription

What to Expect From Merck & Co.'s Next Quarterly Earnings Report

Merck & Co. will release its first-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.

Barchart

Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance

Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.

Investors Business Daily

Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan

Pharma names whipsawed Wednesday after Trump said he would enact "major" tariffs on drug imports and then backed off his tariffs — for now.

Investors Business Daily

Biotech Stocks Take A Tariffs Hit. Pharmaceuticals Are Exempt — For Now.

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe.

Investors Business Daily

Analysts at Trump ally Howard Lutnick’s former firm call RFK Jr. ‘an anti-vax, conspiracy theorist with inadequate training’

RFK Jr. was reportedly behind the ouster of FDA’s top vaccine official and said last week that around 10,000 employees will be laid off at the Department of Health and Human Services.

Fortune

Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?

AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks.

Investors Business Daily

Merck Stock Just Reminded Us Why ‘Buy the Dip’ Is Not That Simple

This healthcare company is down more than 30% over the past 52 weeks but still may not be a good buy for value investors.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?

The FDA is due to make an approval decision on injectable Keytruda by mid-September. The move could bolster downtrodden Merck stock.

Barchart

Is Merck Stock Underperforming the S&P 500?

Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Wall Street Predict 92% Upside for This Dividend Stock: Should You Buy It Now?

While there are short-term headwinds, Merck has a bright future ahead.

MarketBeat

Merck: 4 No-Brainer Reasons to Buy This Dip

Merck & Co. stock was pummeled by 10% after its earnings release on soft forecasts, but the overreaction by the market may present a buying opportunity.

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Apple, Coca-Cola, IBM, Berkshire Hathaway: These companies are facing a DEI shareholder showdown in 2025

A fresh crop of shareholder proposals that would have once been unremarkable are now a closely watched battlefront in the war against corporate diversity and inclusion initiatives.

Investors Business Daily

Stock Market Sideways Amid Trump Tariff, Inflation Fears; Palantir, Google, Amazon Among Key Movers: Weekly Review

The stock market was up and down with Trump tariff fears in focus. Palantir led big earnings winners. Google and Amazon were losers.

Fortune

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back.

Investors Business Daily

15 Stocks' Profit Grows Faster Than Any Of The Magnificent Seven

The Magnificent Seven stocks in the S&P 500 get lots of attention — for some good reasons. But top profit growth isn't one of them.

Fortune

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Kiplinger

Stock Market Today: Earnings Speak Louder Than Tariffs

Recent market reaction to Trump administration policy announcements has been "entirely normal."

Investors Business Daily

Stock Market Today: Nasdaq, Small Caps Lead; Costco Among Multiple Breakouts (Live Coverage)

The Nasdaq dominated the major indexes Tuesday. Costco hit a new high and is in a buy zone.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Freedom of Information Act

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.